The 2026 Regulatory Landscape The legal foundation for compounded GLP-1 medications shifted in early 2026
"This is the first clinical trial to demonstrate that semaglutide may improve liver fibrosis in patients with advanced MASH, including those with compensated cirrhosis," said Rohit Loomba, MD, senior author of the study, gastroenterologist and hepatologist at UC San Diego Health and chief of the Division of Gastroenterology and Hepatology at UC San Diego School of Medicine
Companion digital solutions can help users develop new behaviors to ensure theyve made a change that will stick for good. Marni Allen, CMO, Bioniq PepsiCo: Negligible impact At PepsiCo, so far at least, the impact of GLP-1 drugs has been negligible, CEO Ramon Laguarta told analysts during the firms latest earnings call
Patients were randomized to a 96-week course of metformin versus vitamin E versus placebo, and the primary outcome was ALT decrease, while histological improvement/NASH resolution was the secondary outcome
Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, et al
It requires a monastic level of commitment to keep yourself healthy and fulfill all the other commitments of family, work, and life